References in periodicals archive ?
Global Glioma Diagnosis and Treatment market is expected to grow at a CAGR of approximately 10.1% during the forecast period, 2017-2023.
In a previous clinical study in 2014, Raabe and other researchers were able to confirm the safety of the mTOR-blocking drug everolimus in patients with paediatric low-grade glioma and found some patients responded to the medicine.
Many slow-growing NF1 gliomas appear susceptible to immunotherapy
18F-fluciclovine PET imaging is being investigated for the detection and continuing assessment of glioma.
For this new trial, 99 patients with suspected high-grade (fast-growing) gliomas were given a drink containing 5-ALA before surgery.
A chordoid glioma is a rare neoplasm that, in 2000, was incorporated into the World Health Organization (WHO) classification of central nervous system tumors (2, 3, 4).
There are no lineage-specific immunohistochemical markers useful for distinguishing astrocytomas from oligodendrogliomas; thus, tumor typing had relied on morphologic identification of astrocytic or oligodendroglial components in a given glioma. Importantly, the new integrated diagnosis based on ATRX and TP53 mutations and 1p19q codel as signature lineage markers for astrocytoma and oligodendroglioma, respectively, shows that the 2 parameters are mutually exclusive, thus completely eliminating the mixed oligoastrocytoma category.
Development of a fluorescein operative microscope for use during malignant glioma surgery: a technical note and preliminary report.
This recent work builds on previous QCRI research published in the journal Cell in 2016 that developed algorithms which identified the different subtypes of glioma based on their aggressiveness.
Accurate detection of glioma recurrence is of paramount importance as it can change the patient's management [2, 3].